Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Ways to improve ocular bioavailability for topical applications].

D Sirbat1, L Marchal-Heussler, M Hoffman

  • 1Cabinet d'Ophtalmologie, 15 rue du Dôme, F-67000 Strasbourg.

Journal Francais D'Ophtalmologie
|June 9, 2000
PubMed
Summary

Eye drops have poor drug bioavailability due to short residence time. Novel formulations like nanoparticles and biodegradable inserts aim to improve ocular drug delivery and effectiveness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[What should we think? Should Diamox and pilocarpine continue to be prescribed?].

Journal francais d'ophtalmologie·2007
Same author

Elevated prothrombin level and shortened clotting times in subjects with type 2 diabetes.

Journal of thrombosis and haemostasis : JTH·2006
Same author

The status of legal termination of pregnancy in South Africa.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2006
Same author

Rates of complication in first-trimester manual vacuum aspiration abortion done by doctors and mid-level providers in South Africa and Vietnam: a randomised controlled equivalence trial.

Lancet (London, England)·2006
Same author

The application of genomic and proteomic technologies in predictive, preventive and personalized medicine.

Vascular pharmacology·2006
Same author

Circulating tissue factor accumulates in thrombi, but not in hemostatic plugs.

Journal of thrombosis and haemostasis : JTH·2006

Area of Science:

  • Ophthalmology
  • Pharmaceutics
  • Drug Delivery

Context:

  • Ocular drug delivery faces challenges due to the eye's anatomy and physiology.
  • Pre-corneal drug residence time is short, leading to poor bioavailability of conventional eye drops.

Purpose:

  • To explore strategies for enhancing ocular drug bioavailability.
  • To overcome limitations of traditional eye drop formulations.

Summary:

  • Conventional eye drops often contain viscosity agents to prolong residence time, but this can cause patient discomfort.
  • Advanced drug delivery systems, including biodegradable inserts, cyclodextrins, liposomes, and nanoparticles, are being developed to improve ocular drug absorption.

Impact:

  • These innovative approaches promise to increase the efficacy of ophthalmic medications.

Related Experiment Videos

  • Improved ocular bioavailability can lead to better patient outcomes and reduced dosing frequency.